SCHEMBL3474066

SCHEMBL3474066

COc1cc2c(OC)c(-c3c(C)cc4c(C(=O)Nc5ccccc5)c(OC)c(OC)cc4c3OC)c(C)cc2c(C(=O)Nc2ccccc2)c1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.52
MEN1 O00255 3/20 0.52
ATM Q13315 1/20 0.46
SMO Q99835 4/20 0.46
KDM4E B2RXH2 2/20 0.45
ALDH1A1 P00352 2/20 0.45
HPGD P15428 1/20 0.45
HTT P42858 1/20 0.44
MAPT P10636 2/20 0.44
POLB P06746 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KCNK3 O14649 1/20 0.43
KCNK9 Q9NPC2 1/20 0.43
EGFR P00533 1/20 0.43
SRC P12931 1/20 0.43
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
TAS1R2 Q8TE23 1/20 0.43
GAA P10253 1/20 0.43
MCL1 Q07820 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3473620 0.91 PGR (0.48) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL637059 0.85 SMN1; SMN2 (0.54) KMT2AMEN1HTTMAPTSMN1; SMN2
SCHEMBL3472763 0.81 TAAR1 (0.58) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL353909 0.80 MEN1 (0.43) KMT2AMEN1ATMKDM4EALDH1A1
SCHEMBL3265536 0.79 BCL2 (0.59) ALDH1A1MAPTPOLBMCL1TDP1
SCHEMBL353111 0.79 TACR3 (0.54) KMT2AMEN1ATMKDM4EALDH1A1
SCHEMBL3471000 0.79 BCL2 (0.59) ALDH1A1MAPTPOLBMCL1TDP1
SCHEMBL2757193 0.76 MEN1 (0.43) KMT2AMEN1ATMKDM4EALDH1A1
SCHEMBL3473276 0.75 ADORA2A (0.49) KDM4EALDH1A1HPGDMAPTSMN1; SMN2
SCHEMBL3622482 0.74 KMT2A (0.53) KMT2AMEN1ATMKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2418942-B1 NAPHTHALENE-BASED INHIBITORS OF ANTI-APOPTOTIC PROTEINS SANFORD-BURNHAM MEDICAL RES INST (US) 2017-08-23 EP disclosed
US-8436207-B2 Naphthalene-based inhibitors of anti-apoptotic proteins BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2013-05-07 US disclosed
US-20100267781-A1 NAPHTHALENE-BASED INHIBITORS OF ANTI-APOPTOTIC PROTEINS BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267781-A1 NAPHTHALENE-BASED INHIBITORS OF ANTI-APOPTOTIC PROTEINS HAX1, BAX, APOL1 KMT2A 4765/4885MEN1 4843/4885ATM 1403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.